News | Computed Tomography (CT) | February 12, 2020

A unique assessment of imaging-based recommendations for the administration of IV recombinant tissue plasminogen activator based on unenhanced brain CT scans

Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke

Appearance of same unenhanced CT scan on three reading systems: E-2620 monitor (Barco) (A), Galaxy S8 Plus (Samsung) smartphone (B) and ThinkPad T460s laptop computer (Lenovo) (C).


February 12, 2020 — Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke, according to an ahead-of-print article in the April issue of the American Journal of Roentgenology (AJR).

To assess reliability and accuracy of IV thrombolysis recommendations made after interpretation of head computed tomography (CT) images of patients with acute stroke symptoms displayed on smartphone or laptop reading systems—compared with those made after interpretation of images displayed on a medical workstation monitor—Antonio J. Salazar at the University of Los Andes in Bogotá, Columbia utilized a factorial design with 188 patients, four radiologists, and three reading systems to produce 2,256 interpretations.

To evaluate reliability, Salazar and colleagues calculated the intraobserver and interobserver agreements using the intraclass correlation coefficient (ICC) and five interpretation variables: hemorrhagic lesions, intraaxial neoplasm, stroke dating (acute, subacute, chronic), hyperdense arteries, and infarct size assessment. Accuracy equivalence tests were also performed for the IV thrombolysis recommendation; for this variable, sensitivity, specificity, and ROC curves were evaluated.

Good or very good intraobserver agreements were observed for all the variables. Specifically, for those variables required to establish contraindications for IV thrombolysis, the agreements were ranked as very good. “This finding is important,” wrote Salazar et al., “because it reflects the good performance of mobile devices to evaluate the most significant imaging variables for clinical decisions.”

For IV thrombolysis recommendation, the main subject of this evaluation, the interobserver agreements for the three reading systems were ranked as very good (ICC > 0.88). Similarly, very good intraobserver agreements were observed for all comparisons (ICC > 0.84). The AUC values (0.83–0.84) and sensitivities (0.94–0.95) for IV thrombolysis recommendation were equivalent among all the reading systems at a 5 percent equivalent threshold.

A unique assessment of imaging-based recommendations for the administration of IV recombinant tissue plasminogen activator based on unenhanced brain CT scans, Salazar also noted: “These results constitute a strong foundation for the development of mobile-based telestroke services because they increase neuroradiologist availability and the possibility of using reperfusion therapies in resource-limited countries.”

For more information: www.arrs.org


Related Content

Feature | Teleradiology | Kyle Hardner

Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology ...

Time November 06, 2025
arrow
News | X-Ray

Oct. 30, 2025 – In collaboration with OBIO, University Health Network (UHN), Canada’s leading hospital and the No. 1 ...

Time November 03, 2025
arrow
News | Magnetic Resonance Imaging (MRI) | Children's Hospital Los Angeles

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...

Time October 31, 2025
arrow
News | FDA

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
Feature | Archive Cloud Storage | Shujah Dasgupta, Vice President, CitiusTech

Almost two-thirds of health systems are already using (or plan to use) the cloud for storing and viewing medical images ...

Time October 30, 2025
arrow
News | Cardiac Imaging

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...

Time October 29, 2025
arrow
News | Radiology Business | Harvey L. Neiman Health Policy Institute

Oct. 27, 2025 — A new study from the Harvey L. Neiman Health Policy Institute found that radiologists who experienced ...

Time October 28, 2025
arrow
News | Endoscopes

Oct. 22, 2025 — Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 ...

Time October 23, 2025
arrow
News | X-Ray

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the ...

Time October 22, 2025
arrow
News | Contrast Media

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive ...

Time October 21, 2025
arrow
Subscribe Now